FDA Orange Book
Generic for Calan
Calan contains verapamil. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
Yes. The generic name for Calan is verapamil. 9 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB, AP. Generics match 4 of the 5 Calan products the Orange Book lists.
Run it in Rivvi
Map Calan and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Calan products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| injectable, injection | 2.5MG/ML | Discontinued | None | 8 | AP |
| tablet, oral | 120MG | Discontinued | None | 2 | AB |
| tablet, oral | 160MG | Discontinued | None | 0 | None |
| tablet, oral | 40MG | Discontinued | None | 2 | AB |
| tablet, oral | 80MG | Discontinued | None | 2 | AB |
NDA 019038, 018817, held by GD SEARLE LLC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Approved generic verapamil
| Company | ANDA | TE code | Approved | Strengths |
|---|---|---|---|---|
| WATSON LABORATORIES INC | 070994 | AB (A-rated, therapeutically equivalent) | October 1, 1986 | 120MG |
| WATSON LABORATORIES INC | 070995 | AB (A-rated, therapeutically equivalent) | October 1, 1986 | 80MG |
| HERITAGE PHARMACEUTICALS INC DBA AVET PHARMACEUTICALS INC | 071881 | AB (A-rated, therapeutically equivalent) | April 5, 1988 | 120MG, 40MG, 80MG |
| WATSON LABORATORIES INC | 072924 | AB (A-rated, therapeutically equivalent) | June 29, 1993 | 40MG |
| EUGIA PHARMA SPECIALITIES LTD | 212965 | AP (A-rated, therapeutically equivalent) | July 6, 2020 | 2.5MG/ML |
| GLAND PHARMA LTD | 214361 | AP (A-rated, therapeutically equivalent) | October 15, 2020 | 2.5MG/ML |
| ZYDUS PHARMACEUTICALS USA INC | 214215 | AP (A-rated, therapeutically equivalent) | October 15, 2020 | 2.5MG/ML |
| HERITAGE PHARMACEUTICALS INC DBA AVET PHARMACEUTICALS INC | 215829 | AP (A-rated, therapeutically equivalent) | March 17, 2022 | 2.5MG/ML |
| MANKIND PHARMA LTD | 214653 | AP (A-rated, therapeutically equivalent) | June 15, 2022 | 2.5MG/ML |
| FRESENIUS KABI USA LLC | 216471 | AP (A-rated, therapeutically equivalent) | April 23, 2024 | 2.5MG/ML |
| ASPIRO PHARMA LTD | 218218 | AP (A-rated, therapeutically equivalent) | November 13, 2025 | 2.5MG/ML |
| KNACK PHARMACEUTICALS INC | 220076 | AP (A-rated, therapeutically equivalent) | July 22, 2026 | 2.5MG/ML |
Questions
Is there a generic for Calan?
Yes. The generic name for Calan is verapamil. 9 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB, AP. Generics match 4 of the 5 Calan products the Orange Book lists.
What is the generic name for Calan?
The active ingredient in Calan is verapamil, per the FDA Orange Book.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.